|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Premiums | |||||
| Services | |||||
| Investment income | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Benefits | |||||
| Operating costs | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Loss on sale of business | |||||
| Interest expense | |||||
| Other expense, net | |||||
| Income before income taxes and equity in net losses | |||||
| Provision for income taxes | |||||
| Equity in net losses | |||||
| Net income | |||||
| Net (income) loss attributable to noncontrolling interests | |||||
| Net income attributable to Humana | |||||
| Basic earnings per common share (in dollars per share) | |||||
| Diluted earnings per common share (in dollars per share) |
Loading...